SC 13G/A | 2021-02-16 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | GNC HOLDINGS, INC. | 0 | 0.0% | EDGAR |
SC 13D/A | 2020-08-10 | Harbin Pharmaceutical Group Co., Ltd. | GNC HOLDINGS, INC. | 60,895,579 | 42.0% | EDGAR |
SC 13G/A | 2020-07-10 | BlackRock Inc. | GNC HOLDINGS, INC. | 149,067 | 0.2% | EDGAR |
SC 13G/A | 2020-06-29 | Tang PC | GNC HOLDINGS, INC. | 3,340,999 | 4.0% | EDGAR |
SC 13D/A | 2020-06-24 | Harbin Pharmaceutical Group Co., Ltd. | GNC HOLDINGS, INC. | 60,738,317 | 41.8% | EDGAR |
SC 13G/A | 2020-05-11 | FMR LLC | GNC HOLDINGS, INC. | 846,948 | 1.0% | EDGAR |
SC 13G/A | 2020-02-07 | FMR LLC | GNC HOLDINGS, INC. | 7,714,120 | 9.1% | EDGAR |
SC 13G | 2020-02-06 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | GNC HOLDINGS, INC. | 5,759,473 | 6.8% | EDGAR |
SC 13G/A | 2020-02-05 | BlackRock Inc. | GNC HOLDINGS, INC. | 6,035,948 | 7.1% | EDGAR |
SC 13D/A | 2019-11-04 | Harbin Pharmaceutical Group Co., Ltd. | GNC HOLDINGS, INC. | 58,813,084 | 41.0% | EDGAR |
SC 13G | 2019-08-22 | Tang PC | GNC HOLDINGS, INC. | 4,951,947 | 5.8% | EDGAR |
SC 13G/A | 2019-02-13 | FMR LLC | GNC HOLDINGS, INC. | 7,877,006 | 9.4% | EDGAR |
SC 13G/A | 2019-02-11 | VANGUARD GROUP INC | GNC HOLDINGS, INC. | 3,744,442 | 4.5% | EDGAR |
SC 13G/A | 2019-02-04 | BlackRock Inc. | GNC HOLDINGS, INC. | 6,124,028 | 7.3% | EDGAR |
SC 13D | 2018-11-19 | Harbin Pharmaceutical Group Co., Ltd. | GNC HOLDINGS, INC. | 56,065,420 | 40.1% | EDGAR |
SC 13G/A | 2018-02-13 | FMR LLC | GNC HOLDINGS, INC. | 7,172,255 | 10.4% | EDGAR |
SC 13G/A | 2018-02-09 | VANGUARD GROUP INC | GNC HOLDINGS, INC. | 5,590,081 | 8.1% | EDGAR |
SC 13G/A | 2018-02-08 | BlackRock Inc. | GNC HOLDINGS, INC. | 4,633,563 | 6.7% | EDGAR |
SC 13G/A | 2017-02-14 | FMR LLC | GNC HOLDINGS, INC. | 9,896,854 | 14.5% | EDGAR |
SC 13G/A | 2017-02-14 | TPG-AXON Management LP | GNC HOLDINGS, INC. | 0 | 0.0% | EDGAR |